Caseware UK (AP4) 2024.0.164 2024.0.164 2024-08-312024-08-314No description of principal activity2023-09-01false4falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 12171966 2023-09-01 2024-08-31 12171966 2022-09-01 2023-08-31 12171966 2024-08-31 12171966 2023-08-31 12171966 c:Director1 2023-09-01 2024-08-31 12171966 d:OfficeEquipment 2023-09-01 2024-08-31 12171966 d:OfficeEquipment 2024-08-31 12171966 d:OfficeEquipment 2023-08-31 12171966 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-09-01 2024-08-31 12171966 d:CurrentFinancialInstruments 2024-08-31 12171966 d:CurrentFinancialInstruments 2023-08-31 12171966 d:CurrentFinancialInstruments d:WithinOneYear 2024-08-31 12171966 d:CurrentFinancialInstruments d:WithinOneYear 2023-08-31 12171966 d:ShareCapital 2024-08-31 12171966 d:ShareCapital 2023-08-31 12171966 d:RetainedEarningsAccumulatedLosses 2024-08-31 12171966 d:RetainedEarningsAccumulatedLosses 2023-08-31 12171966 c:FRS102 2023-09-01 2024-08-31 12171966 c:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 12171966 c:FullAccounts 2023-09-01 2024-08-31 12171966 c:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 12171966 2 2023-09-01 2024-08-31 12171966 e:PoundSterling 2023-09-01 2024-08-31 iso4217:GBP xbrli:pure

Registered number: 12171966









EMOLYNE COSMETICS LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 AUGUST 2024

 
EMOLYNE COSMETICS LIMITED
REGISTERED NUMBER: 12171966

BALANCE SHEET
AS AT 31 AUGUST 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
2,393
4,731

  
2,393
4,731

Current assets
  

Stocks
  
528,145
711,896

Debtors: amounts falling due within one year
 5 
96,950
24,684

Cash at bank and in hand
 6 
918,165
387,724

  
1,543,260
1,124,304

Creditors: amounts falling due within one year
 7 
(5,333,143)
(3,873,204)

Net current liabilities
  
 
 
(3,789,883)
 
 
(2,748,900)

Total assets less current liabilities
  
(3,787,490)
(2,744,169)

  

Net liabilities
  
(3,787,490)
(2,744,169)


Capital and reserves
  

Called up share capital 
  
1
1

Profit and loss account
  
(3,787,491)
(2,744,170)

  
(3,787,490)
(2,744,169)


Page 1

 
EMOLYNE COSMETICS LIMITED
REGISTERED NUMBER: 12171966
    
BALANCE SHEET (CONTINUED)
AS AT 31 AUGUST 2024

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 29 August 2025.




Emolyne Ramlov
Director

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
EMOLYNE COSMETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

1.


General information

Emolyne Cosmetics Limited is a private limited company limited by share capital. The company is incorporated in England and Wales, company number 12171966. The company's registered office is located at 1 The Green, Richmond Surrey TW9 1PL.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The company is in its infancy and, as a result, is reliant on financial support. The company director is satisfied that support is available for the company, as required, for the foreseeable future 

 
2.3

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of income and retained earnings within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 3

 
EMOLYNE COSMETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

2.Accounting policies (continued)

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
2.5

Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives, which range from 3 to 6 years.
If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

 
2.6

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.7

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 4

 
EMOLYNE COSMETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

2.Accounting policies (continued)

 
2.8

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.9

Development costs

During the year the company incurred costs developing it's products. All costs relating to development undertaken in the year is reflected in these financial statements

 
2.10

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.11

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

Page 5

 
EMOLYNE COSMETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

2.Accounting policies (continued)

 
2.12

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.13

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.14

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

2024
2023
£
£

Wages and salaries
179,484
119,308

Social security costs
16,693
10,787

Cost of defined contribution scheme
8,663
6,800

204,840
136,895


The average monthly number of employees, including directors, during the year was 4 (2023 - 4).

Page 6

 
EMOLYNE COSMETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

4.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 September 2023
9,352



At 31 August 2024

9,352



Depreciation


At 1 September 2023
4,621


Charge for the year on owned assets
2,338



At 31 August 2024

6,959



Net book value



At 31 August 2024
2,393



At 31 August 2023
4,731


5.


Debtors

2024
2023
£
£


Trade debtors
1,188
1,188

Other debtors
92,258
19,991

Prepayments and accrued income
3,504
3,505

96,950
24,684



6.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
918,165
387,724

918,165
387,724


Page 7

 
EMOLYNE COSMETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
8,221
49,690

Other creditors
5,324,922
3,823,514

5,333,143
3,873,204



8.


Pension commitments

The pays contributions to employee's autoenrolment pension scheme. All contributons payable in the year and the liability outstanding at the end of the year are reflected in these accounts.

 
Page 8